Welcure Drugs & Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported revenue was INR 0.09 million. Net loss was INR 0.063 million compared to INR 0.135 million a year ago.
For the six months, revenue was INR 0.09 million compared to INR 0.226 million a year ago. Net loss was INR 0.628 million compared to INR 0.375 million a year ago. Basic loss per share from continuing operations was INR 0.05 compared to INR 0.03 a year ago.